Source: Annual Congress 2002 - Pulmonary embolism and functional imaging
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. S. Marino, C. G. Rhodes, M. Constantinou, S. L. Waters, S. Osman, K. Poole, P. W. Ind (London, United Kingdom). Lung deposition and kinetics of 18F-Fluticasone Propionate (18F-FP) in patients with mild asthma. Eur Respir J 2002; 20: Suppl. 38, 2651

Member's Comments

No comment yet.

Related content which might interest you: Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Lung function measured by multiple breath inert gas washout in children with severe asthma (SA) before and after intramuscular triamcinolone Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children Year: 2013 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Mucociliary clearance (MCC) in the trachea in mild-moderate COPD occurs in spirals Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015 Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014 Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006 Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD? Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Effect of roflumilast on lung function: Results from 180-days study in subjects With severe COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Lung deposition of extrafine vs non-extrafine triple therapies in patients with COPD using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019 Double-tracer gas washout in stable asthma and COPD Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Bronchial fibrocyte accumulation in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Calculation of Scond between 0 and 3 lung turn over (Scond*) in mild to moderate chronic lung disease Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016 Deposition of inhaled nanoparticles, airflow obstruction and emphysema Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Bullous emphysema and severe COPD in acetylated opium users Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013